Published 2 hours ago
Presented by Alkermes
We are proud to announce that we have received the 2022 #BellSealforWorkplaceMentalHealth in Platinum from mental health america! This recognition demonstrates our strong commitment to fostering a mentally healthy workplace for all of our employees. Learn more: https://bit.ly/3kLe6oQ
About Alkermes
Alkermes plc is a fully integrated global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing plant in Wilmington, Ohio. For more information, visit the Alkermes website at www.alkermes.com.
Alkermes
Alkermes
Alkermes plc is a fully integrated global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing plant in Wilmington, Ohio. For more information, visit the Alkermes website at www.alkermes.com.
More of Alkermes
.
